细胞内蛋白质结合Zr-89氧素细胞标记用于PET细胞跟踪研究
Emmanuel Nyong1,2, Yutaka Kurebayashi1,3, Kingsley O Asiedu1,4
1Molecular Imaging Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Pharmaceutics
|April 26, 2025
概括
与印度-111氧 (111In-oxine) 相比,-89氧 (89Zr-oxine) 的细胞内蛋白质结合和保留能力优于-111氧 (111In-oxine) 通过正子发射断层扫描 (PET) 进行长期细胞跟踪. 这种稳定的结合增强了体内细胞可视化,持续长达两周.
科学领域:
- 放射化学 放射化学是指辐射化学.
- 细胞生物学 细胞生物学
- 核医学是一种核医学.
背景情况:
- 使用氧化-89 (89Zr-oxine) 的ex vivo细胞标记允许在体内使用正子发射断层扫描 (PET) 进行细胞跟踪,长达两周.
- 了解89Zr的细胞内结合和分布对于优化细胞标记协议至关重要.
研究的目的:
- 研究影响89Zr-oxine标记的因素以及89Zr在各种细胞类型中的细胞内分布.
- 为了比较89Zr-oxine与11In-oxine的蛋白质结合稳定性和细胞内定位.
主要方法:
- 多种细胞类型 (主要免疫细胞和细胞系) 被标记为89Zr-oxine或111In-oxine.
- 确定了蛋白质结合,标记值和放射性保留.
- 进行了无线图和生物分布研究,以评估结合稳定性和体内保留.
主要成果:
- 89Zr-oxine的结合与细胞大小和蛋白质质量相关,主要在细胞质,膜和核部分与蛋白质结合>97%.
- 相比之下,111In-oxine表现出较低的蛋白质结合 (59-65%) 和细胞质局部化.
- 89Zr-oxine在所有亚细胞分数中表现出稳定的蛋白质结合,而111In-oxine表现出不稳定的结合. 在体内研究显示,89Zr标记细胞的保留率更高.
结论:
- 与111In-oxine相比,89Zr-oxine表现出明显更高和更稳定的细胞内蛋白质结合.
- 89Zr-oxine的稳定,广泛的细胞内蛋白质结合支持其在使用PET的长期体内细胞跟踪中的有效性.
相关概念视频
Positron Emission Tomography
3.9K
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
3.9K
Imaging Studies II: Positron Emission Tomography and Scintigraphy
39
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Fundamental Principles of PET
39


